Drawing for OCULIS

USPTO serial 50186951

OCULIS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with OCULIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary Margaret L. O'Donnell

772 E. Maple RoadBirmingham, MI 48009United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of central nervous system diseases and conditions; Pharmaceutical preparations in the nature of liquid solutions for the treatment of ophthalmic diseases of humans; Eye drops for medical and pharmaceutical purposes; Topical drug formulation for ophthalmic use; Pharmaceutical preparations for the neuroprotective treatment of optic neuritis; Pharmaceutical preparations for the treatment of non-arteritic anterior ischemic optic neuropathyACTIVE—
042(Based on Use) Research and development of pharmaceutical products and medicines addressing ophthalmic and neuro-ophthalmic conditions; Research and development of pharmaceutical preparations for the treatment of eye diseases and conditions; Laboratory research services in the field of eye diseases and conditions; Laboratory research services in the field of ophthalmic and neuro-ophthalmic conditions (Based on Intent to Use) Research and development of pharmaceutical preparations for the treatment of central nervous system diseases and conditions; Laboratory research services in the field of central nervous system diseases and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 28, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance